Category Archive for "Published"

Home »

Quick Thoughts: BAC – Capital Restatement is a Bitter Pill, but Expect $15bn Stock Buyback in 2015

BAC is resubmitting its 2014 (“CCAR”) capital plan to the Fed after discovering an accounting error (related to structured notes acquired with Merrill in 2009) which reduces Tier 1 common capital at December 2013 by $3.7bn and the common-equity (“CET1”)

Read More

US Natural Gas – Not Out of the Woods Yet!

US natural gas pricing remains fairly close to its 52 week high (Exhibit 1), as the very low inventories created by the cold winter are showing limited signs of rebuild (Exhibit 2).  This is happening at a time in the

Read More

SSR Health New Product Approval Portfolios & Supporting Data

Please see the SSR Health YouTube channel for podcasts of recent research Drug, biotech, and research-based spec pharma stocks tend to outperform their peers in the year or so before and after regulatory actions (‘PDUFA’ dates) on major new products,

Read More

Quick Thoughts: V – Cuts 2014 Revenue Guidance and Reorganizes for Merchant “Outreach”

V traded down over 4% in extended hours after delivering in-line results but lowering growth guidance for 2014 to single-digits (10-11% in constant currency with a 2% currency headwind); the firm cited weakness in cross-border volumes and a downshift in

Read More

Quick Thoughts – HSY

Hershey’s Q1 results this morning struck a familiar note within staples and the broader market this earnings season – miss on revenues, meet or beat on EPS.   HSY constant currency organic sales increased 3.2% (2.4% reported, shy of consensus by

Read More

Quick Thoughts: Barclays – Moment of Truth

The market took in its stride Barclays pre-announcement that 20143Q1 profits would be lower than last year’s GPB1.79bn because of weak FICC revenues; the stock is up over 1% today at GPB2.52 and well above the GBP2.36 of March 11th

Read More

US Banking: Mobile Banking Will Increase Scale Economies

Despite a strong rally off October 2011 lows, large-bank valuations remain attractive with WFC, JPM, and BAC trading at price-to-book multiples of 60%, 40% and 30% relative to the S&P500 – at or below the low-end of pre-crisis ranges. Valuations

Read More

Quick Thoughts: Discover Checking Account Offers Durbin-Advantaged Rewards

DFS beat on EPS ($1.31 vs. $1.25 consensus) and continued to outpace the industry in loan growth (5% year-on-year in card and student, and 26% and 27% in private-student and personal lending respectively); with double-digit account growth in card, we

Read More

PFE/AZN: R&D Productivity in the Context of a Theoretical Merger

The data in this note are extracted from: “Biopharmaceuticals R&D Productivity: Metrics, Benchmarks, and Rankings for the 22 Largest (by R&D spending) US-Listed Firms”, available at www.hiddenpipeline.com Increasing firm size = declining R&D productivity, both across (larger firms produce less

Read More

Corn Planting Progress Remains Sluggish

As of Sunday, 6% of the U.S. corn crop had been planted versus a five year average of 14% – a slow start to be sure.  Significant progress was made across more Southern locations (Louisiana was virtually completed, for example)

Read More
test